Ki-67 Labeling Index in Glioblastoma; Does it Really Matter?
ConclusionThe difference between the survival curves of patients with Ki-67 labeling index of ≤ 27%, and Ki-67 of> 27% was statistically insignificant (p = .130). Therefore, Ki-67 labeling index alone cannot predict survival in glioblastoma patients.
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Glioma | Hematology | Middle East Health | Neurology | Saudi Arabia Health | Statistics | Stem Cell Therapy | Stem Cells | Study